Pharmacology & Toxicology eJournal最新文献

筛选

英文中文

Secondary Metabolites from Plants: The Thin Border Between Beneficent and Harmful 植物次生代谢物:有益与有害之间的细微界限

Pharmacology & Toxicology eJournal Pub Date : 2019-04-25 DOI: 10.2139/ssrn.3388066

Georgiana Mardare (Balusescu), T. Măluțan

引用次数: 1

TCF7L2 Promotes Osteogenic Differentiation and Boron-Induced Bone Repair Via Lipocalin 2 TCF7L2通过脂钙蛋白2促进成骨分化和硼诱导的骨修复

Pharmacology & Toxicology eJournal Pub Date : 2019-01-10 DOI: 10.2139/ssrn.3313307

Chengcheng Yin, Xiaoshi Jia, Qin Zhao, Zifan Zhao, Jinyang Wang, Hui Fu, Zubing Li, Yufeng Zhang

{"title":"TCF7L2 Promotes Osteogenic Differentiation and Boron-Induced Bone Repair Via Lipocalin 2","authors":"Chengcheng Yin, Xiaoshi Jia, Qin Zhao, Zifan Zhao, Jinyang Wang, Hui Fu, Zubing Li, Yufeng Zhang","doi":"10.2139/ssrn.3313307","DOIUrl":"https://doi.org/10.2139/ssrn.3313307","url":null,"abstract":"Boron-containing mesoporous bioactive glass (B-MBG) scaffolds are capable of promoting osteogenesis during the process of bone defect repair. Despite this, the involving molecular controls are still largely unclear. We identified that transcription factor 7-like 2 (TCF7L2) served as a key effector promoting boron-induced bone regeneration through lipocalin 2. Lipocalin 2 was highly expressed in osteoblasts treated with B-MBG scaffolds extraction than MBG, as well as TCF7L2. Lipocalin 2, as a secreted bone factor, positively affected osteogenic differentiation of MC3T3-E1 and osteogenesis in vivo, which can be induced by TCF7L2. In addition, interference of TCF7L2 decreased the osteogenic differentiation of MC3T3-E1 in vitro, as well as bone mass, and width growth plate in Ubc-Cre;Tcf7l2fl/fl mice. Finally, we identified lipocalin-2 as a pivotal factor that can rescue the poor ability of osteogenic differentiation of MC3T3-E1 in which TCF7L2 gene was knocked down by lentiviral transfection of shRNA. Our findings provide some new insights into the molecular controls of boron-associated bone regeneration and potential therapeutic targets for the treatment of bone defects.","PeriodicalId":137529,"journal":{"name":"Pharmacology & Toxicology eJournal","volume":"132 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123231627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0